Impact of the COVID-19 Pandemic on Inpatient Antibiotic and Antifungal Drug Prescribing Volumes in Germany
Similar to what has been observed in a majority of European countries, the total volume of antibacterial drug use in German acute care hospitals decreased with the pandemic, without a rebound phenomenon in 2022. In association with restricted hospital capacities and presumably more immunocompromised general medicine patients, however, inpatient prescribing of (primarily broad-spectrum) antibacterials and of antifungal drugs increased.
Authors
- Michaela Steib–Bauert
- Gesche Först (ORCID: https://orcid.org/0009-0009-6236-6597)
- Katja de With (ORCID: https://orcid.org/0000-0001-9473-3018)
- Winfried V. Kern (ORCID: https://orcid.org/0000-0003-2550-358X)
- Evelyn Kramme
- Jürgen Baumann
Institutions
- University of Freiburg (DE)
- Deutsche Gesellschaft für Information und Wissen (DE)
- University Hospital Schleswig-Holstein (DE)
- Federal Union of German Associations of Pharmacists (DE)
- Internationale Akademie Berlin (DE)
- University Hospital Carl Gustav Carus (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Antibiotics
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3390/antibiotics13090837
- Citations
- 5
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 1.49